Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision indicator changed from v3.6.4 to v3.6.5, indicating a new version of the page. This change does not affect study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-11T08:29:55.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces v3.6.3 as the site revision indicator, reflecting a small update to the page. This change does not affect study data or how the page functions.
    Difference
    0.1%
    Check dated 2026-07-28T04:50:19.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.2 to v3.6.3, indicating an administrative update to the study record. This reflects an administrative change rather than updates to the study data.
    Difference
    0.1%
    Check dated 2026-07-06T15:49:14.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the study page. There is no change to substantive study information such as eligibility criteria, endpoints, or locations.
    Difference
    0.1%
    Check dated 2026-06-29T08:46:16.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate enrollment is closed, reflecting a completed study. Additional changes introduce new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a revision label update, signaling UI/content organization updates.
    Difference
    0.4%
    Check dated 2026-06-14T20:37:55.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page now displays a newer revision label, v3.5.5, replacing the previous v3.5.4. This reflects a maintenance or content-management update rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-07T15:51:10.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.